EMEA-001914-PIP01-15

Key facts

Active substance
  • Olmesartan medoxomil
  • rosuvastatin calcium
Therapeutic area
Cardiovascular diseases
Decision number
P/0166/2016
PIP number
EMEA-001914-PIP01-15
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
  • Prevention of cardiovascular events
  • Treatment of dyslipidaemia
  • Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Daewoong Pharmaceutical Co., Ltd.
Republic of Korea
Tel. +82 221906470 / +82 221906774
Fax +82 25508660
Email: gmkang294@daewoong.co.kr / oscar23@daewoong.co.kr
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating
Average
1 rating